Baird Medical Investment (BDMD) Short Interest Ratio & Short Volume

Short interest is the volume of Baird Medical Investment shares that have been sold short but have not yet been closed out or covered. As of August 31st, investors have sold 59,900 shares of BDMD short. 0.48% of Baird Medical Investment's shares are currently sold short. Learn More on Baird Medical Investment's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.48% of Baird Medical Investment's floating shares are currently sold short.

Baird Medical Investment saw a decrease in short interest in the month of August. As of August 31st, there was short interest totaling 59,900 shares, a decrease of 32.7% from the previous total of 89,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Baird Medical Investment currently has issued a total of 35,730,000 shares. Some of Baird Medical Investment's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Baird Medical Investment currently has a public float of 12,480,000 shares.

0.48% of Baird Medical Investment's shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to Baird Medical Investment: Alpha Tau Medical Ltd. (0.18%), NeuroPace, Inc. (4.29%), ClearPoint Neuro, Inc. (8.89%), Sanuwave Health Inc. (5.95%), The Beauty Health Company (21.10%), Tactile Systems Technology, Inc. (9.80%), Sanara MedTech Inc. (7.83%), Brainsway Ltd. Sponsored ADR (1.25%), Outset Medical, Inc. (11.48%), Perspective Therapeutics, Inc. (10.49%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($73.23 billion), Invesco QQQ ($29.52 billion), iShares Russell 2000 ETF ($20.82 billion), iShares 20+ Year Treasury Bond ETF ($10.76 billion), Palo Alto Networks, Inc. ($9.37 billion), Strategy Inc ($7.58 billion), Invesco S&P 500 Equal Weight ETF ($6.78 billion), SPDR S&P Biotech ETF ($6.72 billion), AppLovin Corporation ($6.37 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($6.29 billion). View all of the most shorted stocks.

Short selling BDMD is an investing strategy that aims to generate trading profit from Baird Medical Investment as its price is falling. BDMD shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Baird Medical Investment occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BDMD, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BDMD, twice per month. The most recent reporting period available is August, 31 2025.